Structure Therapeutics Stock News
$27.28
2.48%
day before yesterday
Nasdaq,
Oct 03, 10:00 pm CET
Industry
Structure Therapeutics Stock News
Positive
The Motley Fool
●
23 days ago
The weight-management market is arguably the hottest therapeutic area in the industry right now. Investors seeking to capitalize on the rapid expansion of this niche can turn to established giants like Eli Lilly and Novo Nordisk.
Neutral
Seeking Alpha
●
25 days ago
Structure Therapeutics Inc. (NASDAQ:GPCR ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 10:45 AM EDT Company Participants Raymond Stevens - CEO & Director Conference Call Participants Terence Flynn - Morgan Stanley, Research Division Presentation Terence Flynn Equity Analyst Great. Thanks for joining us, everyone.
Neutral
GlobeNewsWire
●
2 months ago
Topline data from oral small molecule GLP-1 receptor agonist aleniglipron ACCESS and ACCESS II studies on track for year-end 2025 readouts
Neutral
GlobeNewsWire
●
4 months ago
SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced two upcoming late-breaking poster presentations at the American Diabetes Association 85th Scientific Sessions, being held from June 20-23 in Chicago, IL.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
